Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family

Journal of the Neurological Sciences

Volumn 213, Issue 1-2, 2003, Pages 25-28

  Wilder Smith, E ^a   Tan, E K ^b   Law, H Y ^c   Zhao, Y ^b   Ng, I ^c   Wong, M C ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

L DOPA sensitive Dystonia; Phenotype; SCA 3; Spinocerebellar atrophy

Indexed keywords

LEVODOPA;

ADULT; ALLELE; ARTICLE; CASE REPORT; CHINESE; CIRCADIAN RHYTHM; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DOPAMINERGIC SYSTEM; DYSTONIA; FAMILY HISTORY; FEMALE; HUMAN; MEDICAL RECORD; MUTATION; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION;

EID: 0038504370     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(03)00129-1     Document Type: Article

References (12)

1. Sequeiros J., Coutinho P. Epidemiology and clinical aspects of Machado-Joseph disease. Harding A.E., Deufel T. Advances in neurology. 1993;139-153 Raven Press, New York.
2. Higgins J.J., Nee L.E., Vasconcelos O., Ide S.E., Lavedan C., Goldfarb L.G.et al. Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA 3 is allelic to Machado-Joseph disease. Neurology. 46:1996;208-213.
3. Tan E.K., Ashizawa T. Genetic testing in spinocerebellar ataxia: defining a clinical role. Arch. Neurol. 58:2001;191-195.
4. Tuite P.J., Rogaeva E.A., St George-Hyslop P.H., Lang A.E. Dopa-responsive parkinsonism phenotype of Machado-Joseph disease: confirmation of 14q CAG expansion. Ann. Neurol. 38:1995;684-687.
5. Gwinn-Hardy K., Singleton A., O'Suilleabhain P., Boss M., Nicholl D., Adam A.et al. Spinocerebellar ataxia type 3 phenotypically resembling Parkinson disease in a black family. Arch. Neurol. 58:2001;296-299.
6. Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M., Katayama S.et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8:1994;221-228.
7. Kyland K., Fryburg J.S., Wilson W.G., Bebin E.M., Arnold L.A., Gunasekera R.S.et al. Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology. 48:1997;1290-1297.
8. Nygaard T.G., Takahashi H., Heiman G.A., Snow B.J., Fahn S., Calne D.B. Long-term treatment response and flurodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia. Ann. Neurol. 32:1992;603-608.
9. Tassin J., Durr A., Bonnet A.M., Gil R., Vidailhet M., Lucking C.B.et al. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain. 123:2000;1112-1121.
10. Schols L., Amoiridis G., Buttner T., Przuntek H., Epplen J.T., Riess O. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann. Neurol. 42:1997;924-932.
11. Takiyama Y., Sakoe K., Nakano I., Nishizawa M. Machado-Joseph disease: cerebellar ataxia and autonomic dysfunction in a patient with the shortest known expanded allele (56 CAG repeat units) of the MJD1 gene. Neurology. 49:1997;604-606.
12. Gwinn-Hardy K., Chen J.Y., Liu H.C., Liu T.Y., Boss M., Seltzer W.et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology. 55:2000;800-805.